Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

A Gasmi, S Noor, T Tippairote, M Dadar, A Menzel… - Clinical …, 2020 - Elsevier
It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II
infection with the current spreading. While a specific treatment is not yet coming soon …

[HTML][HTML] The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19

AN Olaimat, I Aolymat, M Al-Holy, M Ayyash… - npj Science of …, 2020 - nature.com
COVID-19 is a pandemic disease caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). This new viral infection was first identified in China …

The role of the lung microbiota and the gut–lung axis in respiratory infectious diseases

A Dumas, L Bernard, Y Poquet… - Cellular …, 2018 - Wiley Online Library
The pulmonary microbial community, described only a few years ago, forms a discreet part
of the human host microbiota. The airway microbiota has been found to be substantially …

[HTML][HTML] Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation

A Raheem, L Liang, G Zhang, S Cui - Frontiers in immunology, 2021 - frontiersin.org
In order to inhibit pathogenic complications and to enhance animal and poultry growth,
antibiotics have been extensively used for many years. Antibiotics applications not only …

[HTML][HTML] Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19

AYK Thye, JWF Law, LTH Tan, P Pusparajah, HL Ser… - Biology, 2022 - mdpi.com
Simple Summary The coronavirus can elude the immune response, potentially spreading to
cells other than the respiratory tract's epithelial cells. The neuro-invasive potential of certain …

Probiotics: A potential immunomodulator in COVID-19 infection management

K Singh, A Rao - Nutrition Research, 2021 - Elsevier
COVID-19 caused by SARS-CoV-2 is an ongoing global pandemic. SARS-CoV-2 affects the
human respiratory tract's epithelial cells, leading to a proinflammatory cytokine storm and …

Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection

L Conte, DM Toraldo - Therapeutic advances in respiratory …, 2020 - journals.sagepub.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel
coronavirus, which only in the European area has led to more than 300,000 cases with at …

Dietary supplements and nutraceuticals under investigation for COVID-19 prevention and treatment

R Lordan, HM Rando, CS Greene - Msystems, 2021 - Am Soc Microbiol
ABSTRACT Coronavirus disease 2019 (COVID-19) has caused global disruption and a
significant loss of life. Existing treatments that can be repurposed as prophylactic and …

[HTML][HTML] Herbal remedies, nutraceuticals, and dietary supplements for COVID-19 management: an update

VP Chavda, AB Patel, D Vihol, DD Vaghasiya… - Clinical Complementary …, 2022 - Elsevier
Currently, the world is facing a Coronavirus pandemic with a grave deficiency of specific
therapy for Coronavirus Disease (COVID-19). Moreover, scientists attempt to discover the …

Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems

O Kanauchi, A Andoh, S AbuBakar… - Current …, 2018 - ingentaconnect.com
Recently, the risk of viral infection has dramatically increased owing to changes in human
ecology such as global warming and an increased geographical movement of people and …